Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (1514)	1/19/2006 3:59:33 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

POZN Opened with a small upgap out of an ascending triangle. It is up 14.10% and volume is now over 1,331,440 bigcharts.marketwatch.com The stock is trading above its April 30 H and seems ready to test its April 8 H at 15.14 <g> bigcharts.marketwatch.com Bernard

To: zeta1961 who wrote (1514)	1/20/2006 2:55:14 AM
From: mopgcw	Read Replies (1) \| Respond to of 3722

zeta, I think INSM will do ok with iplex, if they survive the IP issue. be careful on your entry price, though, as last time i looked, they are living hand to mouth, with about 20mm in the bank 14 of which is convert; and burning 7-9mm/qrt. ipex is a small indication and the bang for buck has always been diabetes which has been tough for them to get any traction. i have traded in and out of them for a few years now since bvf/ctrx days. bvf still has a small stake. of course I am most likely way off, and they will survive the IP, iplex will give them revenue to survive and the stock will go to $30... geo